-+ 0.00%
-+ 0.00%
-+ 0.00%

Jefferies Downgrades Pacira BioSciences to Hold, Announces $36 Price Target

Benzinga·10/08/2026 20:01:05
Listen to the news
Jefferies analyst Glen Santangelo downgrades Pacira BioSciences (NASDAQ:PCRX) from Buy to Hold and announces $36 price target.